0001104659-15-049025.txt : 20150630
0001104659-15-049025.hdr.sgml : 20150630
20150630184803
ACCESSION NUMBER: 0001104659-15-049025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150630
FILED AS OF DATE: 20150630
DATE AS OF CHANGE: 20150630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jirousek Michael
CENTRAL INDEX KEY: 0001394939
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 15962734
MAIL ADDRESS:
STREET 1: C/O SIRTRIS PHARMACEUTICALS, INC.
STREET 2: 790 MEMORIAL DR. SUITE 104
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
a4.xml
4
X0306
4
2015-06-30
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001394939
Jirousek Michael
C/O CATABASIS PHARMACEUTICALS, INC. ONE
KENDALL SQUARE BLDG. 1400E, SUITE B14202
CAMBRIDGE
MA
02139
0
1
0
0
Chief Scientific Officer
Common Stock
2015-06-30
4
C
0
66658
A
245684
D
Common Stock
2015-06-30
4
C
0
409
A
246093
D
Series A Preferred Stock
2015-06-30
4
C
0
856571
0
D
Common Stock
66658
0
D
Series B Preferred Stock
2015-06-30
4
C
0
5261
0
D
Common Stock
409
0
D
The Series A and Series B Preferred Stock converted into Common Stock on a 1-for-12.85 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
/s/ Michael Jirousek
2015-06-30